Rebound insomnia and hypnotic self administration

Abstract

Twenty-one (three groups of seven), men and women, 25–50 years of age were studied to determine whether or not rebound insomnia would increase the likelihood of self administering a benzodiazepine (triazolam 0.25 mg) hypnotic. The groups compared were patients with insomnia and disturbed sleep, insomnia and normal sleep, and healthy normals. Rebound insomnia, by both subjective and polysomnographic assessment, was induced. The experience of rebound insomnia did not increase the likelihood of self administering a benzodiazepine hypnotic in any of the groups. There were clear group differences in pill self administration with normals rarely and insomnia patients frequently, but not differentially (placebo versus active drug) self administering pills.

DOI: 10.1007/BF02245259

7 Figures and Tables

Statistics

05001000'94'97'00'03'06'09'12'15
Citations per Year

2,007 Citations

Semantic Scholar estimates that this publication has 2,007 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Roehrs1992ReboundIA, title={Rebound insomnia and hypnotic self administration}, author={Timothy A. Roehrs and Lori Merlotti and Frank J Zorick and Thomas Roth}, journal={Psychopharmacology}, year={1992}, volume={107}, pages={480-484} }